Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366691169> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W4366691169 endingPage "208" @default.
- W4366691169 startingPage "200" @default.
- W4366691169 abstract "Neuropathic pain is a very troublesome disease that seriously affects human life. Eriocalyxin B (EriB) has been revealed to attenuate various diseases through its anti-inflammatory effects, but its regulatory effects on neuro-pathic pain remains unclear. The paw withdrawal threshold and paw withdrawal thermal latency were detected through mechanical allodynia and thermal hyperalgesia tests. The spinal injury was assessed through hematoxylin and eosin staining. The cell apoptosis was measured through terminal deoxynucleotide transferase-mediated dUTP nick end-labeling assay. The protein expressions were examined through Western blot analysis. The mRNA expression was examined through reverse transcription-quantitative polymerase chain reaction. The ionized calcium-binding adaptor molecule 1 level in the spinal cord was evaluated through immunofluorescence assay. The levels of tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 were measured through enzyme-linked-immunosorbent serologic assay. The chronic constriction injury (CCI) rat model was constructed for the study. Our results demonstrated that EriB relieved CCI-stimulated neuropathic pain and nerve damage. In addition, the enhanced neural apoptosis mediated by CCI induction was reduced after EriB treatment. In addition, EriB inhib-ited CCI-induced microglia activity and inflammation. At last, the Janus kinase 2–signal transducer and activator of transcription 3 (JAK2/STAT3) and nuclear factor kappa B (NF-κB) pathways were activated in CCI rat model, which were attenuated following EriB treatment. Importantly, EriB (10 mg/kg) had a strong effect that was similar to the positive control (1-μg/kg dexmedetomidine), suggesting that EriB may be an effective drug for neuropathic pain. This study demonstrated that EriB inhibited inflammation caused by CCI-induced microglia activation to relieve neuropathic pain through inhibition of JAK2/STAT3 and NF-κB pathways. This study may highlight the regulatory functions of EriB in the treatment of neuropathic pain." @default.
- W4366691169 created "2023-04-24" @default.
- W4366691169 creator A5005746207 @default.
- W4366691169 creator A5069753373 @default.
- W4366691169 date "2023-04-20" @default.
- W4366691169 modified "2023-09-30" @default.
- W4366691169 title "Eriocalyxin B inhibits inflammation induced by CCI-induced microglia activation to relieve neuropathic pain through inhibition of JAK2/STAT3 and NF-κB pathways" @default.
- W4366691169 doi "https://doi.org/10.15586/qas.v15i2.1270" @default.
- W4366691169 hasPublicationYear "2023" @default.
- W4366691169 type Work @default.
- W4366691169 citedByCount "0" @default.
- W4366691169 crossrefType "journal-article" @default.
- W4366691169 hasAuthorship W4366691169A5005746207 @default.
- W4366691169 hasAuthorship W4366691169A5069753373 @default.
- W4366691169 hasBestOaLocation W43666911691 @default.
- W4366691169 hasConcept C104317684 @default.
- W4366691169 hasConcept C15490471 @default.
- W4366691169 hasConcept C170493617 @default.
- W4366691169 hasConcept C171958077 @default.
- W4366691169 hasConcept C17991360 @default.
- W4366691169 hasConcept C185592680 @default.
- W4366691169 hasConcept C190283241 @default.
- W4366691169 hasConcept C203014093 @default.
- W4366691169 hasConcept C2776415932 @default.
- W4366691169 hasConcept C2776914184 @default.
- W4366691169 hasConcept C2777107010 @default.
- W4366691169 hasConcept C2778923194 @default.
- W4366691169 hasConcept C2779245659 @default.
- W4366691169 hasConcept C2779830541 @default.
- W4366691169 hasConcept C55493867 @default.
- W4366691169 hasConcept C71924100 @default.
- W4366691169 hasConcept C87753298 @default.
- W4366691169 hasConcept C98274493 @default.
- W4366691169 hasConceptScore W4366691169C104317684 @default.
- W4366691169 hasConceptScore W4366691169C15490471 @default.
- W4366691169 hasConceptScore W4366691169C170493617 @default.
- W4366691169 hasConceptScore W4366691169C171958077 @default.
- W4366691169 hasConceptScore W4366691169C17991360 @default.
- W4366691169 hasConceptScore W4366691169C185592680 @default.
- W4366691169 hasConceptScore W4366691169C190283241 @default.
- W4366691169 hasConceptScore W4366691169C203014093 @default.
- W4366691169 hasConceptScore W4366691169C2776415932 @default.
- W4366691169 hasConceptScore W4366691169C2776914184 @default.
- W4366691169 hasConceptScore W4366691169C2777107010 @default.
- W4366691169 hasConceptScore W4366691169C2778923194 @default.
- W4366691169 hasConceptScore W4366691169C2779245659 @default.
- W4366691169 hasConceptScore W4366691169C2779830541 @default.
- W4366691169 hasConceptScore W4366691169C55493867 @default.
- W4366691169 hasConceptScore W4366691169C71924100 @default.
- W4366691169 hasConceptScore W4366691169C87753298 @default.
- W4366691169 hasConceptScore W4366691169C98274493 @default.
- W4366691169 hasIssue "2" @default.
- W4366691169 hasLocation W43666911691 @default.
- W4366691169 hasOpenAccess W4366691169 @default.
- W4366691169 hasPrimaryLocation W43666911691 @default.
- W4366691169 hasRelatedWork W2088783314 @default.
- W4366691169 hasRelatedWork W2102092354 @default.
- W4366691169 hasRelatedWork W2380665308 @default.
- W4366691169 hasRelatedWork W2594859188 @default.
- W4366691169 hasRelatedWork W2973768374 @default.
- W4366691169 hasRelatedWork W3006433254 @default.
- W4366691169 hasRelatedWork W3160039572 @default.
- W4366691169 hasRelatedWork W3205161990 @default.
- W4366691169 hasRelatedWork W4294768395 @default.
- W4366691169 hasRelatedWork W4318262802 @default.
- W4366691169 hasVolume "15" @default.
- W4366691169 isParatext "false" @default.
- W4366691169 isRetracted "false" @default.
- W4366691169 workType "article" @default.